Stockscreener 앱 받기
154.54
3.16%
-5.04
시간 외 거래:
145.55
-8.99
-5.82%
Charles River Laboratories International Inc 주식(CRL)의 최신 뉴스
Stock Analysis | Charles River Laboratories International OutlookA Weak Technical Profile But Strong Fundamentals - AInvest
Pharmaceutical company to expand Charleston County operations - Live 5 News
Healthcare firms see growing activist investor involvement in the past year - Reuters
Charles River Labs scales back Memphis project, slashes expected jobs - The Business Journals
Clinical Trial Biorepository and Archiving Solutions Market Size Expected to Attain USD 9.69 Billion by 2034 - GlobeNewswire Inc.
Earnings call transcript: Charles River Labs Q2 2025 beats EPS forecasts - Investing.com Canada
FRAUD AND MANIPULATION—1st Cir.: CEO’s reaction to macaque conspiracy was actionably misleading - VitalLaw.com
Huge proposed Memphis project downsizes by 500 jobs - The Business Journals
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Are Margin Pressures Shaping Charles River’s (CRL) Competitive Position Amid Stabilizing Revenue Guidance? - simplywall.st
Is Charles River Laboratories International Inc. exposed to currency risksPortfolio Gains Summary & Real-Time Volume Trigger Notifications - sundaytimes.kr
How Charles River Laboratories International Inc. stock reacts to Fed policy changesQuarterly Growth Report & Verified Swing Trading Watchlists - beatles.ru
Day 5 of Gains Streak for Charles River Laboratories International Stock with 5.3% Return (vs. -15% YTD) [8/15/2025] - Trefis
Charles River Laboratories International Inc. Stock Recovery Path — Analyst Breakdown2025 Market Sentiment & AI Enhanced Execution Alerts - sundaytimes.kr
Profitable Stocks to Watch: Dole, Charles River Laboratories, and LegalZoom - AInvest
Charles River Laboratories International Inc. Recovery Linked to Earnings Surprise2025 Analyst Calls & Real-Time Market Sentiment Alerts - sundaytimes.kr
Why Charles River Laboratories International Inc. stock attracts strong analyst attentionJuly 2025 Technicals & Weekly High Conviction Trade Ideas - sisa-n.com
What is Charles River Laboratories International Inc. s 5 year growth outlookJuly 2025 Final Week & Accurate Intraday Trading Signals - sundaytimes.kr
Custom Dashboard Highlights Charles River Laboratories International Inc. Price MomentumEarnings Recap Summary & Technical Entry and Exit Tips - 선데이타임즈
5 Revealing Analyst Questions From Charles River Laboratories’s Q2 Earnings Call - Yahoo Finance
Do Charles River (CRL) Earnings Trends Reveal Shifting Priorities in Its Advanced Therapeutics Ambitions? - simplywall.st
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Yahoo Finance
CRL Stock Gains on Q2 Earnings and Revenue Beat, Raises '25 View - MSN
Interpreting Charles River (CRL) International Revenue Trends - Yahoo Finance
Charles River Labs: Buy Rating and $179 Price Target Amidst Stability and Value Creation Potential - AInvest
Charles River Laboratories Q2 2025 Earnings Call Transcript Summary - AInvest
Charles River Laboratories International Inc's Q2 2025 Financials and Strategic Direction: A SWOT Analysis - AInvest
Charles River Laboratories Reports Q2 2025 Earnings - The Globe and Mail
Charles River Laboratories International Inc. stock underperforms Wednesday when compared to competitors - MSN
Charles River Laboratories International 2025 Q2 Earnings Misses Targets as Net Income Drops 44% - AInvest
Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2025 Earnings Call Transcript - Insider Monkey
Charles River Laboratories International Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Charles River Laboratories Q2 2025 Earnings Preview - MSN
Charles River Laboratories International Q2 2025 Earnings Call Transcript - MarketBeat
Charles River Laboratories International 2025 Q2 Earnings Beats Expectations as Net Income Drops 44.1% - AInvest
Charles River: Q2 Earnings Snapshot - Milford Mirror
Charles River Labs Reports Mixed Q2 Earnings Call - TipRanks
Charles River Laboratories Shares Drop 10.25% Despite 49.73% Volume Surge Ranking 339th in Market Activity as Order Cancellations Weigh on Investor Sentiment - AInvest
Charles River (CRL) Q2 EPS Jumps 11% - The Globe and Mail
Charles River Labs stock price target raised to $175 by BofA Securities - Investing.com India
Charles River Laboratories Q2 2025 Earnings Call Transcript Review - AInvest
Charles River Sees Limited Impact From NIH Cuts, Tariffs, Drug Pricing - Benzinga
Charles River: Margin Fears Outweigh Solid Q2 (NYSE:CRL) - Seeking Alpha
Charles River Labs cleared in DOJ monkey investigation, provides strategic review update - The Business Journals
Deutsche Bank Adjusts Price Target on Charles River Laboratories International to $185 From $180 - MarketScreener
Charles River Laboratories (CRL) Q2 Earnings and Revenues Surpass Estimates - sharewise.com
Charles River (CRL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
2.12%
0.82%
자본화:
|
볼륨(24시간):